Practice guidelines for neuropathic pain management;Parámetros de práctica para el manejo del dolor neuropático

Revista de Investigacion Clinica

Volumn 58, Issue 2, 2006, Pages 126-138

  Guevara López, Uriah ^a   Covarrubias Gómez, Alfredo ^a   García Ramos, Guillermo ^a   Hernández Jiménez, Sergio ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Diabetic neuropathy; Neuropathic pain; Postherpetic neuralgia; Practice guidelines; Trigeminal neuralgia

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; BACLOFEN; CAPSAICIN; CARBAMAZEPINE; CLOMIPRAMINE; CLONAZEPAM; DESIPRAMINE; DEXTROMETHORPHAN; GABAPENTIN; IMIPRAMINE; INDOMETACIN; LAMOTRIGINE; LEVODOPA; LIDOCAINE; LORAZEPAM; METHYLPREDNISOLONE; MEXILETINE; MORPHINE; OXCARBAZEPINE; OXYCODONE; PHENYTOIN; PLACEBO; PREGABALIN; TIZANIDINE; TOCAINIDE; TOPIRAMATE; TRAMADOL; UNINDEXED DRUG; VALPROIC ACID;

ARTICLE; COCHRANE LIBRARY; DATA ANALYSIS; DIABETIC NEUROPATHY; DISEASE CLASSIFICATION; EMBASE; EVIDENCE BASED PRACTICE; HUMAN; INCIDENCE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDLINE; NEUROPATHIC PAIN; PATIENT CARE; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; SYMPTOM; TRIGEMINUS NEURALGIA; UNITED STATES;

DIABETIC NEUROPATHIES; HUMANS; NEURALGIA, POSTHERPETIC; PAIN; PRACTICE GUIDELINES; TRIGEMINAL NEURALGIA;

EID: 33745794659     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Merskey H. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions. Pain 1986; S-3: 345-56.
2. Merskey H. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. International Association for the Study of Pain. Task force on taxonomy. IASP press; 1994.
3. Dworkin RH, Backonja MM, Robotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell CM, et al. Advances in neuropathic pain: Diagnosis, mechanisms and treatment recommendations. Arch Neurol 2003; 60: 1524-34.
4. Jensen TS, Gottrup H, Sindrup SH, Bach FW. The clinical picture of neuropathic pain. Eur J Pharmacol 2001; 429: 1-11.
5. Dworkin RH. An overview of neuropathic pain: Syndromes, symptoms; signs, and several mechanisms. Clin J Pain 2002; 18: 343-9.
6. Bennett GJ. Neuropathic pain: an overview. In: Borsook D, ed. Molecular neurobiology of pain. Seattle, WA: IASP Press; 1997, pp. 109-13.
7. Schmader KE. Epidemiology and impact in Quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002; 18: 350-4.
8. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000. Tomo 2. La salud de los adultos. Cuernavaca, Morelos, México; Instituto Nacional de Salud Pública; 2003.
9. Aguilar-Salinas CA, Velazquez-Monroy O, Gómez-Peres FJ, González-Chavez A, Lara-Esqueda A, Molina-Cuevas V, et al. Characteristics of patients with type 2 diabetes in Mexico. Diabet Care 2003; 26: 2021-6.
10. Browsher D. The lifetime occurrence of herpes zoster and prevalence of post-herpetic neuralgia: A retrospective in the elderly population. Eur J Pain 1999; 3: 335-42.
11. Bridges D, Thompson SWN, Rice ASC. Mechanisms of neuropathic pain. Br J Anest 2001; 87: 12-26.
12. Ashburn MA, Caplan RA, Connis RT, Ginsberg B, Green CR, Arbor A, et al. Practice guidelines for acute pain management in the perioperative setting: An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2004; 100: 1573-81.
13. Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1979; 121: 1193-1254.
14. Woolf SH, Battista RN, Anderson GM, et al. Assessing the clinical effectiveness of preventative maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. J Clin Epidemiol 1990; 43: 891-905.
15. US Preventive Services Task Force. Screening for adolescent idiopathic scoliosis: review article. JAMA 1993; 269: 2667-72.
16. U.S. Preventive Services Task Force Ratings: Strength of Recommendations and Quality of Evidence. Guide to Clinical Preventive Services, Third Edition. Periodic Updates, 2000-2003. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/ratings.htm
17. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users' guides to the medical literature: IX: A method for grading health care recommendations. JAMA 1995; 274: 1800-4.
18. Guevara-López U, Moyao-García D. Parámetros de práctica para el manejo del dolor agudo perioperatorio. Rev Mex Anest 2002; 25: 277-88.
19. Guevara-López U, Covarrubias-Gómez A, DeLille-Fuentes R, Hernández-Ortíz A, Carrillo-Esper R, Moyao-García D. Parámetros de práctica para el manejo del dolor agudo perioperatorio. Cir Cir 2005; 73: 223-32.
20. National Health and Medical Research Council. Acute Pain Management: Scientific Evidence. Canberra, Australia: NHMRC; 1999.
21. Galer BS, Jensen MP. Development and preliminary validation of pain measure specific to neuropathic pain: The neuropathic pain scale. Neurology 1997; 48: 332-8.
22. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associates with nervous or somatic lesions an development of a new neuropathic pain diagnostic questionnaire (DN-4). Pain 2005; 114: 29-36.
23. Ramunssen PV, Sinderup SH, Jensen TJ, Bach FW. Symptoms and signs in patients with suspected neuropathic pain. Pain 2004; 110: 461-9.
24. Simmons Z, Feldman EL. Update on diabetic neuropathy. Curr Opin Neurol 2002; 15: 595-603.
25. Mendell JR, Sahenk Z. Painful sensory neuropathy. N Engl J Med 2003; 348: 1243-55.
26. Podwall D, Gooch C. Diabetic neuropathy: Clinical features, etiology and treatment. Curr Neurol Neurosci 2004; 4: 55-61.
27. Tenser R. Trigeminal neuralgia: Mechanisms and treatment. Neurology 1998; 51: 17-19.
28. Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain 2001; 124: 2347-60.
29. Zakrzewska JM. Diagnosis and differential diagnosis of trigeminal neuralgia. Clin J Pain 2002; 18: 14-21.
30. Ali JM, Gebarski S, Thompson BG. Transient magnetic resonance imaging signal alterations in the brainstem after microvascular decompression for trigeminal neuralgia: case report. Neurosurgery 2004; 55: E1023-E1026.
31. Chavez-Chavez GR, De Salles AAF, Solberg TD, Pedroso A, Espinosa D, Villablanca P. Three-dimensional fast imaging employing steady-state acquisition magnetic resonance imaging for sterotactic radiosurgery of trigeminal neuralgia. Neurosurgery 2005; 56: E628.
32. Johnson RW, Dworkin RH. Treatment of herpes zoster and postherpetic neuralgia. BJM 2003; 326: 748-50.
33. Gnann JW, Whitley RJ. Herpes zoster. N Engl J Med 2002; 347: 340-6.
34. Feldman EL, Russell JW, Sullivan KA, Golovoy D. New insights into the pathogenesis of diabetic neuropathy. Corr Opin Neurol 1999; 12: 553-63.
35. Verrotti A, Giuva T, Morgese G, Chiarelli F. New trend in the etiopathogenesis of diabetic neuropathy. J Child Neurol 2001; 16: 389-94.
36. Diabetic control and complications trial research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
37. Diabetic control and complications trial research group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122: 561-8.
38. Rull JA, Quibrera R, González-Millán H, Lozano-Castañeda O. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: double-blind crossover study. Diabetología 1969; 5: 215-20.
39. Wilton T. Tegretol in the treatment of diabetic neuropathy. Afr Med J 1974; 27: 869-72.
40. Gómez-Pérez FJ, Choza R, Ríos JM, Reza A, Huerta E, Aguilar CA, Rull JA. Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Res 1996; 27: 525-9.
41. Beydoun A, Kobetz SA, Carrazana EJ. Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy. Clin J Pain 2004; 20: 174-8.
42. Chadda VS, Mathur M. double-blind effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc Physicians India 1978; 26: 403-6.
43. Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical neuropathy. Clin Pharmacol Ther 1977; 22: 196-99.
44. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study. Neurology 2001; 57: 505-9.
45. Backonja M, Beydoun A, Edwards KR, Shwartz SL, Fonseca V, Hes M, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. J Am Med Assoc 1998; 280: 1831-6.
46. Gorson KC, Schott C, Herman R, Ropper AH, Rand WM. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 1999; 66: 251-2.
47. Tamez-Perez HE, Rodriguez AM, Gomez DO. Use of gabapentin on neuropathic diabetic pain. Med Intern Mex 1998; 14: 251-3.
48. Backonja MM. Use of anticonvulsivants for treatment of neuropathic pain. Neurology 2002; 59: S14-S17.
49. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999; 159: 1931-7.
50. Dallocchio C, Buffa C, Mazzarello P, Chiroli S. Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. J Pain Symptom Manage 2000; 20: 280-5.
51. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004; 110: 628-38.
52. Backonja MM, Serra J. Pharmacologic management part 1: better-studied neuropathic pain diseases. Pain Med 2004; 5: S28-S47.
53. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326: 1250-6.
54. Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987; 37: 589-96.
55. Sindrup SH, Gram LF, Brøsen K, Eshøj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990; 42: 135-44.
56. Sindrup SH, Gram LF, Skjold T, Grodum E, Brosen K, Beck-Nielsen H. Clomipramine vs. desipramine vs. placebo in the treatment of diabetic neuropathy symptoms: A double-blind cross-over study. Br J Clin Pharmacol 1990; 30: 683-91.
57. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000; 55: 915-20.
58. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, et al. Double-blinded randomized trial of tramadol for the treatment of pain of diabetic neuropathy. Neurology 1998; 50: 1842-6.
59. Jung BF, Johnson RW, Griffin DRJ, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62: 1545-51.
60. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: treatment of postherpetic neuralgia. An evidence-based report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2004; 6: 959-65.
61. Kost RG, Straus SE. Postherpetic neuralgia: pathogenesis, treatment, and prevention. N Engl J Med 1996; 335: 32-42.
62. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. N Z Med J 1989; 102: 93-5.
63. Harding SP, Porter SM. Oral acyclovir in herpes zoster ophthalmicus. Curr Eye Res 1991; 10: 177-82.
64. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330: 896-900.
65. McKendrick MW, McGill JI, White JE, Wood MJ. Oral acyclovir in acute herpes zoster. BMJ 1986; 293: 1529-32.
66. Whitley RJ, Weiss H, Gnann J, et al. The efficacy of steroid and acyclovir therapy of herpes zoster in the elderly. J Invest Med 1995; 43: 252A.
67. Huff JC, Bean B, Balfour HH Jr, et al. Therapy of herpes zoster with oral acyclovir. Am J Med 1988; 85: 84-9.
68. Wood MJ, Ogan PH, McKendrick MW, Care CD, McGill JI, Webb EM. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 1988; 85: 79-83.
69. Eaglstein WH, Katz R, Brown JA. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA 1970; 211: 1681-3.
70. Clemmensen OJ, Andersen KE. ACTH versus prednisone and placebo in herpes zoster treatment. Clin Exp Dermatol 1984; 9: 557-63.
71. Keczkes K, Basheer AM. Do corticosteroids prevent post-herpetic neuralgia? Br J Dermatol 1980; 102: 551-5.
72. Opstelten W, Van Wijck AJM, Stalker RJ. Interventions to prevent post herpetic neuralgia: cutaneous and percutaneous techniques. Pain 2004; 107: 202-6.
73. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280: 1837-42.
74. Rice ACS, Maton S. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain 2001; 94: 215-24.
75. Sabatowsky R, Galván R, Cherry DA, Jacquot F, Vincent E, Maisonobe P, Versavel M. Pregabaline reduces pain and improves sleep and mood disturbances in patients with postherpetic neuralgia: results of a randomized, placebo-controlled clinical trial. Pain 2004; 109: 26-35.
76. Dworkin RH, Corbin AE, Young JP, Jr., et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003; 60: 1274-83.
77. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988; 38: 1427-32.
78. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982; 32: 671-3.
79. Graff-Radford SB, Shaw LR, Naliboff BN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 2000; 16: 188-92.
80. Watson CPN, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: A randomized, double-blind, crossover trial. Pain 1992: 48: 29-36.
81. Watson CPN, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial. Neurology 1998; 51: 1166-71.
82. Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 1998; 50: 1837-41.
83. Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2002; 59: 1015-21.
84. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in postherpetic neuralgia: A randomized, double-blind, placebo-controlled trial. Pain 2003; 104: 323-31.
85. Davies PS, Galer BS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 2004; 64: 937-47.
86. Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993; 15: 510-26.
87. Tremont-Lukats IW, Megeff C, Backonja MM. Anticonvulsants for neuropathic pain syndromes: Mechanisms of action and place in therapy. Drugs 2000; 60: 1029-52.
88. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 2002; 18: 22-7.